Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine hCG Flushing in ICSI
NCT06684951Phase 4Completed
- Start
- Oct 2022
- Primary completion
- Jan 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of human chorionic gonadotropin in female infertility (3 arms). Primary endpoints: Serum Tumor Necrosis Factor-alpha, Serum Interleukin-10 and 4 more. Started Oct 2022; status: completed.
02
Drugs
human chorionic gonadotropin
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT06684951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06684951.